APOE and early-onset autosomal dominant Alzheimer disease: Apolipoprotein E (APOE) and clusterin (CLU) involved in cholesterol transport and metabolism, are associated with an increased risk of Alzheimer’s disease (AD), indicating the underlying predictive roles of cholesterol metabolism in cognitive decline [18–21].